Analysis of DNA-phosphate adducts in vitro using miniaturized LC-ESI-MS/MS and column switching: phosphotriesters and alkyl cobalamins

Johanna Haglund, Walter Van Dongen, Filip Lemière, Eddy L Esmans, Johanna Haglund, Walter Van Dongen, Filip Lemière, Eddy L Esmans

Abstract

DNA-phosphate adducts are known to be formed by a variety of alkylating agents. Due to little or no repair of DNA-phosphate adducts, these adducts may offer increased possibilities of both identifying and quantifying DNA adducts. The formation of DNA-phosphate adducts leads to a complete esterification of the phosphate group giving rise to a phosphotriester configuration. This work consists of the characterization of ethyl phosphotriesters (Ethyl PTE) using miniaturized LC-ESI-MS/MS and column switching in enzymatic hydrolysate of DNA treated in vitro with the model compound N-ethyl-N-nitrosourea (ENU). In vitro ENU-treated DNA was enzymatically degraded using nuclease P1, phosphodiesterase, and alkaline phosphatase. The use of column switch allowed for large-volume injections, where unmodified nucleosides were discarded in the loading step. The analytes were forward flushed to the analytical column in the eluting step and separated using a linear gradient. Ten different ethyl PTEs (dGpEtdG, dApEtdA, dCpEtdC, TpEtT, dGpEtdA, dGpEtdC, dGpEtT, dApEtdC, dApEtT, and dCpEtT) were characterized by their masses and CAD product ion spectra. Measurements of accurate masses were carried out yielding experimental masses within 5 ppm of the calculated masses for 9 of the 10 ethyl PTEs. For comparison, the enzymatic hydrolysate of ENU-treated DNA was subjected to transalkylation of the DNA-phosphate adducts by cob(I)alamin. Formed ethyl-cobalamins were analyzed according to earlier developed methods. The limit of detection of an alkyl-cobalamin standard and an alkyl PTE standard was 2 fmol and 5 fmol, respectively.

References

    1. J Am Soc Mass Spectrom. 2003 May;14(5):482-91
    1. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Oct 5;778(1-2):279-308
    1. Carcinogenesis. 1987 Jun;8(6):751-7
    1. Chem Res Toxicol. 1997 Jan;10(1):70-7
    1. Pharmacol Rev. 1966 Mar;18(1):805-38
    1. Int J Radiat Biol Relat Stud Phys Chem Med. 1975 Apr;27(4):355-62
    1. Anal Chem. 1996 Oct 15;68(20):3575-84
    1. Chem Res Toxicol. 2002 Jun;15(6):773-9
    1. Nature. 1969 Jul 12;223(5202):206-7
    1. Biochem J. 1978 Jun 1;171(3):575-87
    1. Br Med Bull. 1964 May;20:91-5
    1. Chem Res Toxicol. 2000 Apr;13(4):253-6
    1. J Am Soc Mass Spectrom. 1992 Jan;3(1):60-70
    1. Carcinogenesis. 1986 Mar;7(3):393-403
    1. J Am Chem Soc. 1971 Dec;93(24):6657-65
    1. Carcinogenesis. 1995 Jul;16(7):1543-8
    1. Acta Chem Scand. 1968;22(8):2727-9

Source: PubMed

3
Subskrybuj